No rapid antigen tests have been removed from the Australian market because they couldn't detect the Omicron COVID-19 variant, the health regulator says.
The Therapeutic Goods Administration issued the public notice on Thursday evening following several incorrect media reports that the RATs were ineffective.
The TGA confirmed only four RATs have so far been cancelled from the Australian Register of Therapeutic Goods, with three being removed by their supplier.
The TGA only cancelled one product because the sponsor couldn't provide sufficient data on the RAT's sensitivity to COVID-19.
"The use of RATs to monitor for SARS-CoV-2 infection is a vital measure in managing the COVID-19 pandemic," the TGA statement said.
"The TGA continues to monitor RAT performance, with information regularly released on the TGA.
"The Doherty Institute is assisting by independently testing manufacturers' claims on test sensitivity."
Australian Associated Press
Sign up for our newsletter to stay up to date.